SHELDON KAPLAN to Methicillin Resistance
This is a "connection" page, showing publications SHELDON KAPLAN has written about Methicillin Resistance.
Connection Strength
2.343
-
Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006 Oct 15; 43(8):953-60.
Score: 0.257
-
Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis. 2006 Jul; 17(3):113-9.
Score: 0.254
-
Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am. 2005 Sep; 19(3):747-57.
Score: 0.240
-
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005 May; 24(5):457-8.
Score: 0.234
-
Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S178-85.
Score: 0.209
-
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002 Oct; 21(10):910-7.
Score: 0.196
-
Staphylococcus aureus retropharyngeal abscess in children. Pediatr Infect Dis J. 2015 Apr; 34(4):454-6.
Score: 0.116
-
Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J. 2010 May; 29(5):410-4.
Score: 0.083
-
Commentary: Prevention of recurrent staphylococcal infections. Pediatr Infect Dis J. 2008 Oct; 27(10):935-7.
Score: 0.074
-
Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics. 2007 Nov; 120(5):937-45.
Score: 0.070
-
Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006 Sep; 118(3):874-81.
Score: 0.064
-
Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006 May; 117(5):1673-9.
Score: 0.063
-
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006 Apr; 25(4):349-53.
Score: 0.062
-
Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006 Feb; 117(2):433-40.
Score: 0.062
-
Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005 Jun 15; 40(12):1785-91.
Score: 0.059
-
Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005 Mar; 115(3):642-8.
Score: 0.058
-
Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar; 24(3):201-6.
Score: 0.058
-
Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004 Aug; 23(8):701-6.
Score: 0.056
-
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
Score: 0.052
-
The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection. Pediatr Infect Dis J. 2017 06; 36(6):572-577.
Score: 0.034
-
Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob Agents Chemother. 1993 Nov; 37(11):2401-6.
Score: 0.026
-
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 2007 Nov 06; 7:99.
Score: 0.017